Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
|
Ryan McBride |
08/07/09 |
Boston
|
|
Biogen Idec, Trying to Go Beyond Rituxan, Assembles Cancer Drug Pipeline
|
Luke Timmerman |
07/16/09 |
Boston
|
|
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/03/09 |
Boston
|
|
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings
|
Luke Timmerman |
06/01/09 |
Boston
|
|
Infinity Sees Comeback Potential for Cancer Drug that Failed
|
Luke Timmerman |
06/01/09 |
Boston
|
|
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/20/09 |
Boston
|
|
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data
|
Luke Timmerman |
05/15/09 |
Boston
|
|
Group Names IBM, Zeemote, Infinity, Wolfe Executives as Leading Women Entrepreneurs
|
Wade Roush |
05/05/09 |
Boston
|
|
Innovating Through the Downturn: The View from the Nantucket Conference
|
Wade Roush |
05/05/09 |
Boston
|
|
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/22/09 |
Boston
|
|
Infinity Pharma Lead Cancer Drug Trial Halted, Ends in Failure
|
Ryan McBride |
04/15/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Biogen Idec Parkinson’s Drug Hits Goal in Pair of Mid-Stage Trials
|
Luke Timmerman |
01/13/09 |
Boston
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca
|
Luke Timmerman |
12/11/08 |
Boston
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Infinity Starts Trial of Hedgehog Pathway Blocker
|
Luke Timmerman |
10/16/08 |
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
Boston
|
|
Infinity Pharmaceuticals Starts First Clinical Trial of Oral Hsp-90 Blocker
|
Luke Timmerman |
07/30/08 |
Boston
|
|
Infinity Adds Two New Members To Board of Directors
|
Luke Timmerman |
07/22/08 |
Boston
|
|
MIT and Startup Sue Affymetrix, Enlight Garners Big Pharma Backers, Genocea Targets Cheaper Vaccines, & More Life Sciences News
|
Rebecca Zacks |
07/16/08 |
Boston
|
|
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer
|
Luke Timmerman |
07/14/08 |
Boston
|
|
Xconomy Forum, December 5: The Future of Innovation in New England
|
Robert Buderi |
11/08/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
